Pressurised metered dose inhalers (pMDI) delivering drugs for asthma, chronic obstructive pulmonary disease and other respiratory diseases currently use hydrofluorocarbon (HFC) propellants that ...

Inhalers, specifically those using pressurised metered-dose inhalers (pMDIs), have a significant carbon footprint due to the ...

Introduction: Because of environmental concerns, the use of chlorofluorocarbons in pressurised metered dose inhalers (pMDI) is being phased out. Innovata Biomed Ltd has developed an alternative ...

for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than traditional pressurised metered-dose inhalers (pMDIs). This month ...

Global pharma major Lupin Limited (Lupin) announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential (GWP). This initiative aims to ...

Australia may soon follow changes made to asthma treatment and management in the UK, where doctors have been ­advised to stop ...

The drug has a marketing authorisation in a pressurised metered-dose inhaler (pMDI), as a maintenance dual bronchodilator to relieve symptoms in adults with COPD. Bevespi, which is taken twice ...

Dr Bwika explains, “Inhalers are just devices useful in the delivery of drugs into the body. But the gases used to propel the medication, particularly in pressurised metered-dose inhalers (pMDIs ...

28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential ...